Consensus SanBio Company Limited

Equities

Market Closed - Japan Exchange Other stock markets 11:30:00 14/05/2024 am IST			5-day change	1st Jan Change
431 ^JPY	+2.86%		+0.23%	-38.60%

19/03	SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March	MT
19/03	Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform	MT

7df962ceda8.igTBriFxgRQW3kTprHq-NKyngSQ7ziSkNOVWZiSDczM.s2C791MbzHdFtyeN7x2LAZjy7hVyh2jBfbEmCmraHEPIUrf8ZwO2bXzuDQ~9a74dbbb3835b6ff61924425d2fd6f64

Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform	19/03	MT
Jefferies Adjusts Sanbio’ Price Target to 310 Yen From 420 Yen, Keeps at Underperform	25/23/25	MT
Jefferies Adjusts SanBio's Price Target to 420 Yen From 550 Yen, Keeps at Underperform	28/23/28	MT
Jefferies Downgrades SanBio to Underperform From Hold, Adjusts Price Target to 550 Yen From 1,100 Yen	20/23/20	MT
Jefferies Starts SanBio at Hold With 1,100 Yen Price Target	23/23/23	MT
Rosier FY23 Economic Outlook Pulls Japanese Shares Out of Losses; Rakuten's S&P Rating Deteriorates	22/22/22	MT

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

431 JPY

Average target price

800 JPY

Spread / Average Target

+85.61%

High Price Target

2,300 JPY

Spread / Highest target

+433.64%

Low Price Target

270 JPY

Spread / Lowest Target

-37.35%

Jefferies & Co.